Cargando…

PROCEEDINGS OF LGMD days MEETING: Prognosis and Treatment in LGMD October 15-17, 2014 IRCCS "S. Camillo", Lido di Venezia (VE), Italy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2014
Materias:	Meeting Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369845/

Ejemplares similares

LGMD. Identification, description and classification
por: Angelini, Corrado
Publicado: (2020)

Disease Progression and Mutation Pattern in a Large Cohort of LGMD R1/LGMD 2A Patients from India
por: Ganaraja, Valakunja H., et al.
Publicado: (2021)

LGMD2I in a North American population
por: Kang, Peter B, et al.
Publicado: (2007)

Tail properties and approximate distribution and expansion for extreme of LGMD
por: Huang, Jianwen, et al.
Publicado: (2017)

A Journey with LGMD: From Protein Abnormalities to Patient Impact
por: Georganopoulou, Dimitra G., et al.
Publicado: (2021)

Current and Future Approaches to Classify VUSs in LGMD-Related Genes
por: Li, Chengcheng, et al.
Publicado: (2022)

The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States
por: Reddy, Hemakumar M., et al.
Publicado: (2016)

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing
por: Yu, Meng, et al.
Publicado: (2017)

Genetic Counseling and NGS Screening for Recessive LGMD2A Families
por: Strafella, Claudia, et al.
Publicado: (2020)

Enhancing LGMD-based model for collision prediction via binocular structure
por: Zheng, Yi, et al.
Publicado: (2023)

Natural history of LGMD2A for delineating outcome measures in clinical trials
por: Richard, Isabelle, et al.
Publicado: (2016)

Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D
por: Sandell, Satu, et al.
Publicado: (2016)

Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T)
por: Oestergaard, S.T., et al.
Publicado: (2016)

Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Finsterer, Josef
Publicado: (2018)

Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F
por: Torella, Annalaura, et al.
Publicado: (2013)

LGMD phenotype due to a new gene and dysferlinopathy investigated by next-generation sequencing
por: Angelini, Corrado I.
Publicado: (2015)

Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D
por: Findlay, Andrew R., et al.
Publicado: (2019)

LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism
por: Costa, Roberta, et al.
Publicado: (2022)

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy: A GRASP-LGMD study
por: Doody, Amy, et al.
Publicado: (2023)

Abstracts of the XXVI Congresso Nazionale - Società Italiana di Neonatologia: Venezia, Italy. 7-10 October 2020
Publicado: (2021)

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome
por: Blandin, Gaëlle, et al.
Publicado: (2013)

Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients
por: Nilsson, Mats I., et al.
Publicado: (2014)

RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice
por: Liu, Jian, et al.
Publicado: (2014)

Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations
por: Savarese, Marco, et al.
Publicado: (2015)

The Author Reply: Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Kim, Kitae, et al.
Publicado: (2018)

Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients
por: Nallamilli, Babi Ramesh Reddy, et al.
Publicado: (2018)

Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery
por: Carotti, Marcello, et al.
Publicado: (2020)

Proceedings of the XI Congress of the Italian Association of Myology Cagliari, May 2011: LGMD 1(F) - A pathogenetic hypothesis based on histopathology and ultrastructure
por: Cenacchi, G., et al.
Publicado: (2011)

The LIDOS.RFQ.Designer Development
por: Bondarev, B I, et al.
Publicado: (2001)

Differential expression profiling between the relative normal and dystrophic muscle tissues from the same LGMD patient
por: Zhang, Yong, et al.
Publicado: (2006)

Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D
por: Bianchini, Elisa, et al.
Publicado: (2014)

Duchenne muscular dystrophy–like phenotype in an LGMD2I patient with novel FKRP gene variants
por: Okazaki, Tetsuya, et al.
Publicado: (2020)

Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B
por: Vallecillo-Zúniga, Mary L., et al.
Publicado: (2021)

LGMD1D myopathy with cytoplasmic and nuclear inclusions in a Saudi family due to DNAJB6 mutation
por: BOHLEGA, SAEED A., et al.
Publicado: (2018)

Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study
por: Willis, Tracey A., et al.
Publicado: (2013)

Respiratory muscle involvement in HNRNPDL LGMD D3 muscular dystrophy: an extensive clinical description of the first Italian patient
por: Malfatti, Edoardo, et al.
Publicado: (2020)

Applying Hickam’s dictum: a case of adult-onset LGMD2I muscular dystrophy and long QT syndrome
por: Sheikh, Ali S F, et al.
Publicado: (2023)

Core-rod myopathy due to a novel mutation in BTB/POZ domain of KBTBD13 manifesting as late onset LGMD
por: Garibaldi, Matteo, et al.
Publicado: (2018)

Long term follow-up and further molecular and histopathological studies in the LGMD1F sporadic TNPO3-mutated patient
por: Gibertini, Sara, et al.
Publicado: (2018)

Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits
por: Thiruvengadam, Girija, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3dso5peudvad81f08nlfqo8iqs